The Current Ratio as of December 2024 (TTM) for Travere Therapeutics, Inc. (TVTX) is 1.71

According to Travere Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.71. This represents a change of -37.84% compared to the average of 2.75 of the last 4 quarters.

Travere Therapeutics, Inc. (TVTX) Historical Current Ratio (quarterly & annually)

How has TVTX Current Ratio performed in the past?

The mean historical Current Ratio of Travere Therapeutics, Inc. over the last ten years is 3.69. The current 1.71 Current Ratio has changed 4.53% with respect to the historical average. Over the past ten years (40 quarters), TVTX's Current Ratio was at its highest in in the June 2020 quarter at 7.23. The Current Ratio was at its lowest in in the December 2014 quarter at 0.35.

Travere Therapeutics, Inc. (TVTX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Travere Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Travere Therapeutics, Inc. (TVTX) Average Current Ratio

How has TVTX Current Ratio performed in the past?

The current Current Ratio of Travere Therapeutics, Inc. (TVTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Travere Therapeutics, Inc. (TVTX) Current Ratio vs. Peers

How is TVTX’s Current Ratio compared to its peers?

Travere Therapeutics, Inc.’s Current Ratio is less than DICE Therapeutics, Inc. (38.14), less than Cytokinetics, Incorporated (9.28), less than Ventyx Biosciences, Inc. (23.52), less than Cogent Biosciences, Inc. (6.44), less than Nuvalent, Inc. (23.07), less than Cerevel Therapeutics Holdings, Inc. (10.22), less than Structure Therapeutics Inc. (27.63), less than Revolution Medicines, Inc. (14.24), less than Akero Therapeutics, Inc. (17.25), less than Avidity Biosciences, Inc. (17.76), less than Protagonist Therapeutics, Inc. (10.70), less than Stoke Therapeutics, Inc. (5.09), less than IDEAYA Biosciences, Inc. (22.93), less than AnaptysBio, Inc. (10.23), less than MeiraGTx Holdings plc (2.34), less than Keros Therapeutics, Inc. (19.03), less than Homology Medicines, Inc. (4.19), less than Legend Biotech Corporation (4.98), less than Vaxcyte, Inc. (17.88), less than Apellis Pharmaceuticals, Inc. (4.36),

Build a custom stock screener for Travere Therapeutics, Inc. (TVTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Travere Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Travere Therapeutics, Inc. (TVTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Travere Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.